Twin infant with lymphatic dysplasia diagnosed with noonan syndrome by molecular genetic testing

Fetal and Pediatric Pathology

Volumn 33, Issue 4, 2014, Pages 253-257

  Mathur, Deepan ^a   Somashekar, Santhosh ^a   Navarrete, Cristina ^a   Rodriguez, Maria M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chylothorax; Genomic DNA sequence; Lymphatic dysplasia; Noonan syndrome; Pulmonary lymphangiectasis

Indexed keywords

GENOMIC DNA; PROTEIN TYROSINE PHOSPHATASE SHP 2; PTPN11 PROTEIN, HUMAN;

ANASARCA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CAUSE OF DEATH; CHYLOTHORAX; DNA SEQUENCE; DYSPLASIA; EDEMA; GENE MUTATION; GENETIC SCREENING; HUMAN; INFANT; LYMPH VESSEL; LYMPHANGIECTASIS; LYMPHATIC MALFORMATION; LYMPHATIC TISSUE DYSPLASIA; MALE; MISSENSE MUTATION; NOONAN SYNDROME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; TWINS; DIZYGOTIC TWINS; FATALITY; GENETICS; LUNG; LYMPHATIC SYSTEM DISEASE; PATHOLOGY;

CHYLOTHORAX; DISEASES IN TWINS; DNA MUTATIONAL ANALYSIS; FATAL OUTCOME; HUMANS; INFANT; LUNG; LYMPHANGIECTASIS; LYMPHATIC ABNORMALITIES; MALE; NOONAN SYNDROME; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; TWINS, DIZYGOTIC;

EID: 84903170709     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.3109/15513815.2014.904026     Document Type: Article

References (16)

1. Noonan JA. Noonan syndrome a historical perspective. Heart Views 2002;3:13-15
2. KobylinskiO.Ueber eine flughoutahnibiche ausbreitung.AmHals Arch Anthoropol 1883;14:342-348
3. Ineke van Der Burgt. Noonan syndrome. Orphanet J Rare Dis 2007;2:4
4. Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab 2011;25(1):161-179
5. Moore KL, Persaud TVN. The Developing Human: Clinically Oriented Embryology. 7th ed. Philadelphia,PA: Saunders; 2003
6. SmeltzerDM,SticklerGB, FlemingRE. Primary lymphatic dysplasia inchildren: Chylothorax, chylous ascites, and generalized lymphatic dysplasia. Eur J Pediatr 1986;145(4):286-292 (Pubitemid 16013114)
7. Strober W, Wochner RD, Carbone PP, Waldmann TA. Intestinal lymphangiectasia: A protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest 1967;46(10):1643-1656
8. Allanson JE. Noonan syndrome. JMed Genet 1987;18(24):9-13. (Pubitemid 17228867
9. Dahlgren J. GH therapy in Noonan syndrome: Review of final height data. Horm Res 2009;72(Suppl. 2):46-48
10. Croonen EA, NillesenWM, Stuurman KE, et al. Prenatal diagnostic testing of the Noonan syndrome genes in fetuses with abnormal ultrasound findings. Eur J Hum Genet 2013;21(9):936-942
11. Neel BG, Gu H, Pao L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 2003;28:284-293. (Pubitemid 36776291
12. Tang TL, Freeman RM Jr, O'Reilly AM, et al. The SH2-containing protein-Tyrosine phosphatase SHPTP2 is required upstream of MAP kinase for early Xenopus development. Cell 1995;80:473-483
13. Qu CK, Nguyen S, Chen J, Feng GS. Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood 2001;97:911-914. (Pubitemid 32154273
14. Zhang EE, Chapeau E, Hagihara K, Feng GS. Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci USA 2004;101:16064-16069. (Pubitemid 39507927
15. SarkozyA,Conti E, Seripa D, et al.Correlation between PTPN11 genemutations and congenital heart defects in Noonan and LEOPARD syndromes. JMed Genet 2003;40:704-708. (Pubitemid 37100705
16. Bhambhani V,Muenke M. Noonan Syndrome. Am Fam Physician 2014;89(1):37-43.